Next Investors logo grey

Podcast: Mathew Cherian on how digitisation is changing healthcare


Published 18-JUN-2020 12:28 P.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

In our latest Finfeed podcast, Mathew Cherian, CEO at Global Health Limited (ASX:GLH) speaks with us about the digitisation of the healthcare industry and what the future of healthcare looks like.

Global Health is an ASX listed leading provider of Digital Health solutions to the Australasian Healthcare Industry. It offers a range of solutions to help health businesses be more efficient and deliver excellent patient care.

These include electronic medical records for health delivery organisations, client management systems for community health, patient administration systems for hospitals, practice management systems, secure messaging for connected care, patient engagement platforms and consumer health records.

Over the past 7 years, the company has invested over $7 million in R&D with the goal of Connected Health Records (CHR) to improve the productivity and efficiency for healthcare delivery organisations, streamline the patient’s journey through the healthcare system, and improve patient outcomes through more collaboration and connectivity between patients and their care teams.

This investment now looks to be bearing significant fruit for the company, with revenue forecast to grow by an estimated 12% year-on-year due to the increase in customer recurring and expansion revenue.

With expenses remaining flat, the Company expects to be EBITDA positive for the 12 months to 30-June 2020.

The company has several significant active opportunities expected in the first half or 2020-2021, while its MasterCare Client Management System for Mental Health is experiencing particularly strong demand as the incidence of people living with Mental Health issues has increased due to the pandemic, the severe bushfires and the drought.

In parallel as a direct result of COVID-19, demand for our SaaS Connected Health Records platforms is growing; in particular its HotHealth digital doorway or patient engagement hub, Lifecard Personal Health Record and ReferralNet Secure Messaging platform for connected care has increased as the healthcare eco-system embraces digital health.

Global Health is expecting a strong 12 months ahead.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.